Evolution of the Average Target: CellaVision AB

Evolution of the Target Price: CellaVision AB

Changes in Analyst Recommendations: CellaVision AB

ec1e.I2HgNLDQEUJqk5scW6pT8IFqfZZgKPAVVMmsvcV-ZmU.UTClU8fnRAEy8tNpOds0vfNZB6crcrxbMLqa7bQoIC8RI69_5aFpAB7Zzg~b41262ae9ab434ee1f8a2cf5a79f2fba
20/07 Danske Bank raises Cellavision target price to 187 kronor (180), reiterates buy - BN FW
20/07 DNB Carnegie raises price target for Cellavision to 180 kronor (175), reiterates buy FW
20/07 Pareto Securities raises target price for Cellavision to 160 kronor (150), reiterates hold FW
14/07 Cellavision expected to report SEK 47m in EBITDA - Factset FW
14/07 Pareto downgrades Cellavision to Hold FW
14/07 Pareto Securities downgrades Cellavision to hold (buy), target price SEK 150 (140) FW
24/06 Danske Bank cuts price target for Cellavision to 180 kronor (185), reiterates buy - BN FW
17/06 Aktiespararna sees upside in CellaVision after share price collapse: issues buy rating FW
15/06 Di sees potential for share price to double in CellaVision: issues buy recommendation (Stock of the Week) FW
27/04 Danske Bank cuts Cellavision price target to 185 SEK (235), reiterates Buy - BN FW
27/04 Nordea cuts Cellavision price target to SEK 180 (228), reiterates Buy FW
27/04 DNB Carnegie cuts Cellavision price target to SEK 211 (235), reiterates Buy FW
27/04 Pareto Securities cuts Cellavision price target to SEK 140 (200), reiterates Buy FW
25/04 Afv issues buy rating on CellaVision FW
21/04 Cellavision expected to report EBITDA of SEK 59 million - Factset FW
14/04 Pareto Securities trims Cellavision price target – maintains Buy rating FW
14/04 Pareto Securities trims Cellavision price target to SEK 200 (215), reiterates Buy FW
01/04 Nordea trims Cellavision price target to SEK 228 (230), reiterates Buy FW
06/02 Danske Bank Raises Target Price for Cellavision to 235 Kronor (230), Reiterates Buy - BN FW
06/02 Nordea Raises Target Price for Cellavision to 230 Kronor (228), Reiterates Buy FW
06/02 Pareto Securities Raises Target Price for Cellavision to 215 Kronor (210), Reiterates Buy FW
03/02 Cellavision Expected to Report EBITDA of SEK 60 Million – Factset FW
16/01 Nordea Lowers Target Price for Cellavision to 228 Kronor (230), Reiterates Buy Recommendation FW
15/01 Pareto Maintains 'Buy' Rating on Cellavision Ahead of Earnings Report – Trading at a Discount to Competitors FW
07/11 Nordea Lowers Target Price for Cellavision to SEK 230 (235), Reiterates Buy Recommendation FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.52%
+13.45%
- - +65.48%
+4.99%
+68.09%
+2.29%
+59.88%
+30.95%
+29.35%
Average +31.56%
Weighted average by Cap. +20.44%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
160.40SEK
Average target price
175.67SEK
Spread / Average Target
+9.52%
High Price Target
187.00SEK
Spread / Highest target
+16.58%
Low Price Target
160.00SEK
Spread / Lowest Target
-0.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. CEVI Stock
  4. Consensus CellaVision AB